HGP1201

DRUG4 trials

Sponsors

Hanmi Pharmaceutical Company Limited

Conditions

Benign Prostatic HyperplasiaErectile DysfunctionHealthyProstatic Hyperplasia

Phase 1

Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904

CompletedNCT02243319

Hanmi Pharmaceutical Company LimitedHealthy

Start: 2014-09-30End: 2014-12-31Updated: 2016-10-20

Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers

CompletedNCT02712411

Hanmi Pharmaceutical Company LimitedErectile Dysfunction, Prostatic Hyperplasia

Start: 2015-07-31End: 2015-09-30Updated: 2016-03-18

PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers

CompletedNCT02715401

Hanmi Pharmaceutical Company LimitedErectile Dysfunction, Prostatic Hyperplasia

Start: 2015-10-31End: 2015-11-30Updated: 2016-03-22

Phase 3

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules

CompletedNCT02667938

Hanmi Pharmaceutical Company LimitedBenign Prostatic Hyperplasia

Start: 2015-03-31End: 2016-05-31Updated: 2016-10-13